Evidence map›Paper›PMID 33924991›Full record

ArticleInternational journal of molecular sciences2021

Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy.

Evdokia Bogdanova, Olga Beresneva, Olga Galkina, Irina Zubina, Galina Ivanova, Marina Parastaeva, Natalia Semenova, Vladimir Dobronravov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  3. Article
  4. Article
  5. The Dysfunction of CaInternational journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Molecular Advances in Hypertension and Blood.International journal of molecular sciences · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Evdokia BogdanovaResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.ORCID 0000-0003-1969-1959
Olga BeresnevaResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.
Olga GalkinaResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.
Irina ZubinaResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.
Galina IvanovaLaboratory of Cardiovascular and Lymphatic Systems Physiology, Pavlov Institute of Physiology, Saint Petersburg 199034, Russia.
Marina ParastaevaResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.
Natalia SemenovaResearch Department of Pathomorphology, Almazov National Medical Research Center, Saint Petersburg 197341, Russia.ORCID 0000-0003-4069-0678
Vladimir DobronravovResearch Institute of Nephrology, Pavlov University, Saint Petersburg 197022, Russia.
Federal Almazov North-West Medical Research Centre · RUPavlov Institute of Physiology of the Russian Academy of Sciences · RU

Funding

Russian Foundation for Basic Research 18-315-00342; 18-015-00425
6 · The paper itself

Abstract

backgroundArterial hypertension (AH) is associated with heart and chronic kidney disease (CKD). However, the precise mechanisms of myocardial remodeling (MR) in the settings of CKD remain elusive. We hypothesized that TRPC6, calcineurin/NFAT, and Wnt/β-catenin signaling pathways are involved in the development of MR in the background of CKD and AH.

methodsEarly CKD was induced by performing a 5/6 nephrectomy (5/6NE) in spontaneously hypertensive rats (SHR-NE). Sham-operated (SO) SHR (SHR-SO) and Wistar Kyoto (WKY-SO) rats served as controls. Systolic blood pressure (SBP), heart rate, myocardial mass index (MMI), serum creatinine, cardiomyocyte diameter (dCM), myocardial fibrosis (MF), serum and kidney α-Klotho levels, myocardial expression of calcineurin (CaN), TRPC6, and β-catenin were measured two months after 5/6NE or SO.

resultsNE-induced kidney dysfunction corresponded to mild-to-moderate human CKD and was associated with an increase in FGF23 and a decrease in renal α-Klotho. The levels of SBP, MMI, dCM, and MF were higher in SHRs compared to WKY-SO as well as in SHR-NE vs. SHR-SO. The MR was associated with increased cardiomyocyte expression of CaN/NFAT and β-catenin along with its intracellular re-distribution. TRPC6 protein levels were substantially elevated in both SHR groups with higher

conclusionsThe Wnt/β-catenin and TRPC6/CaN/NFAT hypertrophic signaling pathways seem to be involved in myocardial remodeling in the settings of AH and CKD and might be mediated by FGF23 and α-Klotho axis.

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninCalcineurinCardiomegalyFibroblast Growth Factor-23HypertensionMaleMyocytes, CardiacNephrectomyNFATC Transcription FactorsRatsRats, Inbred SHRRats, Inbred WKYRenal Insufficiency, ChronicTRPC Cation Channelsbeta CateninCalcineurinFGF23 protein, humanFibroblast Growth Factor-23NFATC Transcription FactorsTrpc6 protein, ratTRPC Cation Channelsarterial hypertensioncalcineurin Acalcineurin Bcardiac remodelingchronic kidney diseasefibroblast growth factor 23KlothoNFATparathyroid hormoneTRPC6β-catenin

Identifiers

PMID33924991
PMCPMC8124394
OpenAlexW3157484442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.